Latest Loan Facilities News

Kingston Resources Limited reported a $1.07 million net cash outflow from operating activities in the December 2024 quarter, maintaining a solid cash balance of nearly $9.9 million supported by a $15 million secured loan facility.

Elementos Limited reports significant progress in its Oropesa and Cleveland tin projects, positioning itself as a key supplier in Europe amid tightening global tin markets.

Vertex Minerals has completed construction and begun commissioning of its Gravity Gold plant at the Reward Gold Mine, supported by significant capital raises and strategic hires.

Tasman Resources has identified six promising drill targets at its Parkinson Dam gold project in South Australia, supported by advanced geophysical analysis and a new high-resolution gravity survey. The company also highlights ongoing investment in Eden Innovations and strategic funding moves.

Tartana Minerals reports robust copper sulphate sales and completes a significant acquisition, positioning itself as a leading explorer and developer in Far North Queensland.

Latin Resources has secured shareholder and court approvals for its acquisition by Pilbara Minerals, marking a pivotal transition for the Salinas Lithium Project in Brazil. The deal positions Salinas as a key global lithium asset under new stewardship.

Uscom Limited reports a 56% increase in cash on hand to $2.17 million for Q2 2024, driven by strategic moves in China and new product regulatory approvals.

Titan Minerals has made significant strides in its Ecuadorian copper and gold projects, securing a $20 million capital raise and progressing key drilling milestones under a major joint venture agreement.

Core Energy Minerals Ltd has fortified its uranium exploration ambitions with a $3.7 million capital raise and strategic acquisitions in South Australia, setting the stage for a busy 2025 exploration calendar.

Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.

Astron Corporation Limited reported a $1.05 million net cash outflow from operations in Q4 2024 but strengthened its liquidity position with a $14.5 million inflow from financing activities, ending the quarter with $13.48 million in cash.

Eden Innovations Ltd reports a striking 158% increase in US OptiBlend® sales for Q2 FY25, alongside expanding international traction for its EdenCrete® products and strategic property sales aimed at debt reduction.